Ferring Pharmaceuticals
Sustainability Report and Carbon Intensity Rankings
Is Ferring Pharmaceuticals doing their part?
Their DitchCarbon score is 50
Ferring Pharmaceuticals has a DitchCarbon Score of 50 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of how much carbon emissions are produced relative to their activities. A higher score would suggest a lower carbon intensity and a stronger commitment to reducing their environmental impact.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Ferring Pharmaceuticals is part of the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Ferring Pharmaceuticals operates in India, a region with a very high carbon intensity rating. This suggests that the company’s sustainability efforts may face challenges due to the high carbon footprint associated with the local energy grid and industrial practices.
Unlock 30+ emissions data points on Ferring Pharmaceuticals
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Ferring Pharmaceuticals
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
8.71%
...this company is doing 8.71% better in emissions than the industry average.
Founded in 1950 and based in Saint-Prex, Switzerland, Ferring Pharmaceuticals operates within the industrial manufacturing sector of the biopharmaceutical industry. As a specialty biopharmaceutical group, Ferring is dedicated to the discovery, development, and marketing of innovative products, particularly in reproductive health, urology, gastroenterology, endocrinology, and orthopaedics. With a strong global presence, the company has subsidiaries in nearly 60 countries and distributes its products across 110 countries.
Good news, Ferring Pharmaceuticals has embraced SBTi commitments
Ferring Pharmaceuticals has pledged to set science-based targets through the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions in line with climate science. This commitment means the company will develop a detailed plan to significantly cut its carbon footprint across its operations and value chain.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.